Funder
Fujian Province Medical "Double High" construction fund
the second batch of special support funds for Fujian Province innovation and entrepreneurship talents
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Liu X, Cheng Y, Sheng W, et al. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol. 2010;10:1465–71.
2. Li T, Liu T, Wang M, Zhang M. Α-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation: a case report. Medicine Baltimore. 2018;37:e12359.
3. Søreide JA. Therapeutic approaches to gastric hepatoid adenocarcinoma: current perspectives. Ther Clin Risk Manage. 2019;15:1469–77.
4. Zeng XY, Yin YP, Xiao H, et al. Clinicopathological characteristics and prognosis of hepatoid adenocarcinoma of the stomach: evaluation of a pooled case series. Curr Med Sci. 2018;6:1054–61.
5. Zhang JF, Shi SS, Shao YF, Zhang HZ. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach. Chin Med J Engl. 2011;10:1470–6.